Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster Effect of H5N1 Influenza Vaccine in Japanese Adults (FLU-PPV-B)
jRCT1090220018Phase 4Completed
- Sponsor
- National Hospital Organization Mie National Hospital
- Start
- Jul 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of attenuated H5N1 avian influenza virus vaccine in influenza (2 arms), sponsored by National Hospital Organization Mie National Hospital. Primary endpoints: HI antibody titer against H5 antigen at 21±7 days post-vaccination, Neutralizing antibody titer against H5N1 influenza virus at 21±7 days post-vaccination and 1 more. Started Jul 2008; status: completed.
02
Drugs
attenuated H5N1 avian influenza virus vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT1090220018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1090220018.